Kairos Pharma, Ltd.
KAPA
$0.48
-$0.01-2.05%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.45M | -5.06M | -4.71M | -3.54M | -2.60M |
| Total Depreciation and Amortization | 160.00K | 160.00K | 160.00K | 160.00K | 160.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 115.00K | 154.00K | 154.00K |
| Total Other Non-Cash Items | 2.65M | 1.93M | 1.77M | 374.00K | 318.00K |
| Change in Net Operating Assets | -806.00K | -1.19M | -2.68M | -1.85M | -1.98M |
| Cash from Operations | -3.44M | -4.16M | -5.34M | -4.71M | -3.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3.60M | 3.60M | 263.00K | 142.00K | 142.00K |
| Total Debt Repaid | -- | -142.00K | -142.00K | -142.00K | -142.00K |
| Issuance of Common Stock | -- | 0.00 | 5.52M | 5.52M | 5.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.06M | 3.06M | 2.71M | 2.76M | -390.00K |
| Cash from Financing | 6.66M | 6.52M | 8.36M | 8.28M | 5.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.22M | 2.36M | 3.01M | 3.58M | 1.18M |